Methadone Test Evidence
Has Caused a False Positive
Cyamemazine
Source Lancelin et al., Clin Chem 2005
What It Found
- Cyamemazine appeared in many patients with unconfirmed methadone screens and produced positivity when added to drug-free urine.
Keep in Mind
- Co-medications were present in some patients.
- The study concerns a particular reagent formulation.
Test Studied
- Roche Integra 800 reformulated KIMS methadone, 300 ng/mL
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 0.05% relative response to Cyamemazine.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS methadone urine application on cobas c 501, Table 4
Also cited: Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
Levomepromazine
Source Lancelin et al., Clin Chem 2005
What It Found
- Patients receiving levomepromazine were among those with unconfirmed screens.
- A spiked concentration of 5 mg/L gave a positive signal.
Keep in Mind
- Historical formulation.
- Personal risk at a given prescribed dose is unknown.
Test Studied
- Roche Integra 800 KIMS methadone
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 4.3% relative response to Levomepromazine.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS methadone urine application on cobas c 501, Table 4
Also cited: Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
Quetiapine
Source Fischer et al., J Clin Psychiatry 2010
What It Found
- Ten quetiapine-treated patients had unexpected positive screens.
- The four urine samples checked by GC-MS contained no methadone.
Keep in Mind
- Six of the ten patients in the later case series lacked urine GC-MS confirmation.
Source Widschwendter et al., Am J Psychiatry 2007
What It Found
- In an earlier series, three people on quetiapine alone repeatedly screened positive in urine despite negative plasma methadone by LC-MS/MS.
Keep in Mind
- The earlier three-person series confirmed plasma rather than the screened urine.
Source Pagaduan, J Anal Toxicol 2026
What It Found
- Quetiapine was also common in a later audit of unconfirmed screens.
Test Studied
- Subsequent Roche clinical audit
Source Lasić et al., Acta Clin Croat 2012
Keep in Mind
- A separate case also involved risperidone, so it cannot isolate quetiapine.
3 sources Fischer et al., J Clin Psychiatry 2010 Widschwendter et al., Am J Psychiatry 2007 Lasić et al., Acta Clin Croat 2012
Test Studied
- Roche COBAS Integra Methadone II (KIMS)
Doxylamine
Source Hausmann et al., J Clin Chem Clin Biochem 1983
What It Found
- Doxylamine poisoning produced a positive methadone screen although mass spectrometry excluded methadone.
Test Studied
- Syva EMIT-dau methadone
Source Syed et al., BMJ Case Rep 2009
What It Found
- Another overdose case reported a similar finding.
Test Studied
- Separate toxicity report
Both sources Hausmann et al., J Clin Chem Clin Biochem 1983 Syed et al., BMJ Case Rep 2009
Keep in Mind
- These cases involved intoxication.
- Ordinary sleep-aid doses were not evaluated.
Alimemazine
Source Lancelin et al., Clin Chem 2005
What It Found
- Alimemazine cross-reacted in spiked urine.
- It was also a co-medication in some clinical cases.
Keep in Mind
- The clinical cases involved other phenothiazines, so they do not isolate alimemazine as the sole cause.
Test Studied
- Roche Integra 800 KIMS methadone
Amitriptyline
Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
What It Found
- The 2009 comparison lists reactivity at 75,000 ng/mL for 10-hydroxyamitriptyline (a metabolite of amitriptyline) on the Biosite Triage screen.
Keep in Mind
- This laboratory comparison used historical reagents.
- It gives no frequency after routine use.
- The result depends on the reagent, the cutoff and the concentration in the specimen.
Tests Studied
- Biosite Triage Methadone (parent drug) screen, Krasowski et al. supplement, K
- METHADONE, row 19
Brompheniramine
Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
What It Found
- The 2009 comparison lists reactivity at 75,000 ng/mL for Brompheniramine on the Biosite Triage screen.
Keep in Mind
- This laboratory comparison used historical reagents.
- It gives no frequency after routine use.
- The result depends on the reagent, the cutoff and the concentration in the specimen.
Tests Studied
- Biosite Triage Methadone (parent drug) screen, Krasowski et al. supplement, K
- METHADONE, row 24
Chlorpromazine
Source Lancelin et al., Clin Chem 2005
What It Found
- A spiked concentration of 20 mg/L of chlorpromazine gave a positive methadone result.
Keep in Mind
- This is an analytical challenge.
- These data do not establish how frequently treatment produces a false-positive clinical result.
Test Studied
- Roche Integra 800 reformulated KIMS methadone, 300 ng/mL
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 1.3% relative response to Chlorpromazine.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS methadone urine application on cobas c 501, Table 4
Also cited: Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
Clemastine
Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
What It Found
- The 2009 comparison lists reactivity at 50,000 ng/mL for Clemastine on the Biosite Triage screen.
Keep in Mind
- This laboratory comparison used historical reagents.
- It gives no frequency after routine use.
- The result depends on the reagent, the cutoff and the concentration in the specimen.
Tests Studied
- Biosite Triage Methadone (parent drug) screen, Krasowski et al. supplement, K
- METHADONE, row 20
Clomipramine
Source Lancelin et al., Clin Chem 2005
What It Found
- A spiked concentration of 100 mg/L of clomipramine gave a positive methadone result.
Keep in Mind
- This is an analytical challenge.
- These data do not establish how frequently treatment produces a false-positive clinical result.
Test Studied
- Roche Integra 800 reformulated KIMS methadone, 300 ng/mL
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 0.22% relative response to Clomipramine.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS methadone urine application on cobas c 501, Table 4
Also cited: Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
Loperamide
Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
What It Found
- The 2009 comparison lists reactivity at 75,000 ng/mL for Loperamide on the Biosite Triage screen.
Keep in Mind
- This laboratory comparison used historical reagents.
- It gives no frequency after routine use.
- The result depends on the reagent, the cutoff and the concentration in the specimen.
Tests Studied
- Biosite Triage Methadone (parent drug) screen, Krasowski et al. supplement, K
- METHADONE, row 23
Pazopanib
Source Hughey and Colby, Clin Chem 2019
What It Found
- In laboratory follow-up of a medical-records study, pazopanib gave a presumptive positive at an estimated 198.4 micrograms/mL.
Keep in Mind
- The experimental result does not establish the frequency of false positives at normal dosing.
Test Studied
- Abbott MULTIGENT methadone, 300 ng/mL
Pentazocine
Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
What It Found
- The 2009 comparison lists reactivity at 100,000 ng/mL for Pentazocine on the Biosite Triage screen.
Keep in Mind
- This laboratory comparison used historical reagents.
- It gives no frequency after routine use.
- The result depends on the reagent, the cutoff and the concentration in the specimen.
Tests Studied
- Biosite Triage Methadone (parent drug) screen, Krasowski et al. supplement, K
- METHADONE, row 22
Pheniramine
Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
What It Found
- The 2009 comparison lists reactivity at 25,000 ng/mL for Pheniramine on the Biosite Triage screen.
Keep in Mind
- This laboratory comparison used historical reagents.
- It gives no frequency after routine use.
- The result depends on the reagent, the cutoff and the concentration in the specimen.
Tests Studied
- Biosite Triage Methadone (parent drug) screen, Krasowski et al. supplement, K
- METHADONE, row 18
Propafenone
Source Hughey and Colby, Clin Chem 2019
What It Found
- In laboratory follow-up of a medical-records study, propafenone gave a presumptive positive at an estimated 83.2 micrograms/mL.
Keep in Mind
- The experimental result does not establish the frequency of false positives at normal dosing.
Test Studied
- Abbott MULTIGENT methadone, 300 ng/mL
Thioridazine
Source Lancelin et al., Clin Chem 2005
What It Found
- A spiked concentration of 100 mg/L of thioridazine gave a positive methadone result.
Keep in Mind
- This is an analytical challenge.
- These data do not establish how frequently treatment produces a false-positive clinical result.
Test Studied
- Roche Integra 800 reformulated KIMS methadone, 300 ng/mL
Depends on the Brand of Test
Diphenhydramine
Source Rogers et al., Pediatr Emerg Care 2010
What It Found
- A child with suspected diphenhydramine ingestion screened positive for methadone.
- GC/MS excluded methadone.
- Added diphenhydramine, but not two tested metabolites, reacted on the same device.
Keep in Mind
- Evidence concerns a rapid kit and a suspected ingestion.
- It does not quantify risk after a usual allergy dose.
Test Studied
- ACON One Step Multi-Drug Multi-Line Screen
Source Lin et al., J Anal Toxicol 2013
What It Found
- The authors observed no interference from Diphenhydramine at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.
Keep in Mind
- This is a single challenge level.
- It cannot rule out interference at a higher concentration or with a different device.
Test Studied
- NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels
Tapentadol
Source Collins et al., J Anal Toxicol 2012
What It Found
- Tapentadol and several metabolites reacted on DRI.
- In one series, all 97 selected unexpected positives contained tapentadol without confirmed methadone.
Keep in Mind
- The separate DRI EDDP screen was negative in direct challenges.
Source Gomila Muñiz et al., Emergencias 2020
What It Found
- A second DRI series found five patients with the same discrepancy.
Source Mullins et al., Clin Toxicol (Phila) 2015
What It Found
- A separate study of 11 patients taking prescribed doses found no false positives on EMIT II.
Keep in Mind
- The 11-person EMIT II study cannot exclude rarer reactions.
Test Studied
- Siemens Syva EMIT II
All 3 sources Collins et al., J Anal Toxicol 2012 Mullins et al., Clin Toxicol (Phila) 2015 Gomila Muñiz et al., Emergencias 2020
Keep in Mind
- The studies used different reagents and cutoffs.
2 sources Collins et al., J Anal Toxicol 2012 Gomila Muñiz et al., Emergencias 2020
Keep in Mind
- The positive DRI series did not count all exposed patients.
Test Studied
- DRI parent-methadone EIA (130 ng/mL in the initial study)
Verapamil
Source Lichtenwalner et al., Clin Chem 1998
What It Found
- A laboratory traced unexpected methadone screens to verapamil metabolites with the earlier reagent.
Source Tsay and Khosropour, Clin Chem 1998
What It Found
- The manufacturer later reported that replacing its antibody in June 1997 corrected the interference.
Both sources Lichtenwalner et al., Clin Chem 1998 Tsay and Khosropour, Clin Chem 1998
Keep in Mind
- The historical result is poor support for blaming verapamil on a modern or unidentified assay.
- Check the exact reagent with the testing laboratory.
Test Studied
- Diagnostic Reagents methadone EIA: historical 1995–96 reagent lots versus antibody introduced in June 1997
Vortioxetine
Source Uljon et al., Clin Chim Acta 2019
What It Found
- Seven patients taking typical vortioxetine doses were positive on MDN2 and negative by GC/MS and on two other immunoassays.
- A metabolite was implicated.
Test Studied
- Roche KIMS Methadone II (MDN2) versus two alternative platforms
Both sources Uljon et al., Clin Chim Acta 2019 Pagaduan, J Anal Toxicol 2026
Keep in Mind
- The hospital findings apply to the Roche method.
- Presence of this medication cannot exclude concurrent methadone.
Chlorpheniramine
Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
What It Found
- The 2009 comparison lists reactivity at 100,000 ng/mL for Chlorpheniramine on the Biosite Triage screen.
- At least one other reagent in the same table showed no reaction.
Keep in Mind
- This laboratory comparison used historical reagents.
- It gives no frequency after routine use.
- The result depends on the reagent, the cutoff and the concentration in the specimen.
Tests Studied
- Biosite Triage Methadone (parent drug) screen, Krasowski et al. supplement, K
- METHADONE, row 25
Cyclobenzaprine
Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
What It Found
- The 2009 comparison lists reactivity at 50,000 ng/mL for Cyclobenzaprine on the Biosite Triage screen.
- At least one other reagent in the same table showed no reaction.
Keep in Mind
- This laboratory comparison used historical reagents.
- It gives no frequency after routine use.
- The result depends on the reagent, the cutoff and the concentration in the specimen.
Tests Studied
- Biosite Triage Methadone (parent drug) screen, Krasowski et al. supplement, K
- METHADONE, row 21
Disopyramide
Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
What It Found
- The 2009 comparison lists reactivity at 10,000 ng/mL for Disopyramide on the Biosite Triage screen.
- At least one other reagent in the same table showed no reaction.
Keep in Mind
- This laboratory comparison used historical reagents.
- It gives no frequency after routine use.
- The result depends on the reagent, the cutoff and the concentration in the specimen.
Tests Studied
- Biosite Triage Methadone (parent drug) screen, Krasowski et al. supplement, K
- METHADONE, row 15
Levacetylmethadol
Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
What It Found
- The 2009 comparison lists 1.5% cross-reactivity for Levacetylmethadol on the Microgenics CEDIA screen.
- At least one other reagent in the same table showed no reaction.
Keep in Mind
- This laboratory comparison used historical reagents.
- It gives no frequency after routine use.
- The result depends on the reagent, the cutoff and the concentration in the specimen.
Tests Studied
- Microgenics CEDIA Methadone (parent drug) screen, Krasowski et al. supplement, K
- METHADONE, row 17
Source Cheever et al., J Anal Toxicol 1999
What It Found
- Levomethadyl (LAAM) added to urine produced strong cross-reactivity in five methadone assays, ranging from 75.3% to 318.3%.
- Its metabolite methadol also reacted strongly in several methods.
Keep in Mind
- The investigators spiked urine; the study did not estimate the frequency after taking levomethadyl.
Test Studied
- Diagnostix and STC ELISAs, Diagnostic Products RIA, Diagnostic Reagents EIA, and Roche KIMS
Mesoridazine
Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
What It Found
- The 2009 comparison lists reactivity at 20,000 ng/mL for Mesoridazine on the Biosite Triage screen.
- At least one other reagent in the same table showed no reaction.
Keep in Mind
- This laboratory comparison used historical reagents.
- It gives no frequency after routine use.
- The result depends on the reagent, the cutoff and the concentration in the specimen.
Tests Studied
- Biosite Triage Methadone (parent drug) screen, Krasowski et al. supplement, K
- METHADONE, row 31
Phencyclidine
Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
What It Found
- The 2009 comparison lists reactivity at 75,000 ng/mL for Phencyclidine on the Biosite Triage screen.
- At least one other reagent in the same table showed no reaction.
Keep in Mind
- This laboratory comparison used historical reagents.
- It gives no frequency after routine use.
- The result depends on the reagent, the cutoff and the concentration in the specimen.
Tests Studied
- Biosite Triage Methadone (parent drug) screen, Krasowski et al. supplement, K
- METHADONE, row 32
Promazine
Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
What It Found
- The 2009 comparison lists reactivity at 50,000 ng/mL for Promazine on the Biosite Triage screen.
- At least one other reagent in the same table showed no reaction.
Keep in Mind
- This laboratory comparison used historical reagents.
- It gives no frequency after routine use.
- The result depends on the reagent, the cutoff and the concentration in the specimen.
Tests Studied
- Biosite Triage Methadone (parent drug) screen, Krasowski et al. supplement, K
- METHADONE, row 27
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 0.19% relative response to Promazine.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS methadone urine application on cobas c 501, Table 4
A Related Drug the Test Picks Up
Methadol
Source Cheever et al., J Anal Toxicol 1999
What It Found
- Added methadol displayed 37.7–97.8% cross-reactivity in these methadone assays.
- It can be a metabolite of both methadone and levomethadyl.
Keep in Mind
- This naming refers to methadol in the test, independently of which substance produced it.
Test Studied
- Diagnostic Reagents EIA, Roche KIMS, Diagnostix ELISA, and Abbott FPIA
The Test Is Made to Find It
Methadone
2 sources Pagaduan, J Anal Toxicol 2026 Neukamm et al., Drug Test Anal 2017
What It Found
- A prescribed methadone dose can give an expected positive on a dedicated methadone test.
Source Wolf et al., J Clin Lab Anal 2014
What It Found
- Laboratories may also measure EDDP separately.
Keep in Mind
- The parent drug and EDDP are different targets.
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 110% for racemic methadone and 1.8% for EDDP relative response.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS methadone urine application on cobas c 501, Table 4
2 sources Pagaduan, J Anal Toxicol 2026 Wolf et al., J Clin Lab Anal 2014
Keep in Mind
- Timing, cutoff and formulation of the assay affect detection.
A Problem With the Urine Sample
Creatinine
Source Fucci, Forensic Sci Int 2005
What It Found
- A case report attributed a false-positive methadone screen to creatinine, a normal constituent of urine.
Keep in Mind
- The indexed letter has no abstract.
- The concentration, frequency and applicability to other methadone screens could not be verified.
- Creatinine is distinct from creatine supplements.
Test Studied
- EMIT dau urine methadone immunoassay
Suspected, but Not Proven
Labetalol
Source Ayala-Lopez et al., J Anal Toxicol 2022
What It Found
- Patients with a record of labetalol use had more unconfirmed positive screens in one hospital study.
- Adding labetalol to urine did not produce a positive on the same device, even at 1,600 micrograms/mL.
Keep in Mind
- A medication list records prior use.
- It cannot identify what was in a particular specimen or which substance produced a signal.
Test Studied
- Alere Integrated E-Z Split Key Cup II urine Methadone (parent drug) screen
Prazosin
Source Ayala-Lopez et al., J Anal Toxicol 2022
What It Found
- Patients with a record of prazosin use had more unconfirmed positive screens in one hospital study.
- Adding prazosin to urine did not produce a positive on the same device, even at 1,600 micrograms/mL.
Keep in Mind
- A medication list records prior use.
- It cannot identify what was in a particular specimen or which substance produced a signal.
Test Studied
- Alere Integrated E-Z Split Key Cup II urine Methadone (parent drug) screen
Chlorprothixene
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 0.1% relative response to Chlorprothixene.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS methadone urine application on cobas c 501, Table 4
Tested: No False Positive Found
Acetaminophen
Source Lin et al., J Anal Toxicol 2013
What It Found
- The authors observed no interference from Acetaminophen at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.
Keep in Mind
- This is a single challenge level.
- It cannot rule out interference at a higher concentration or with a different device.
Test Studied
- NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels
Dextromethorphan
Source Lin et al., J Anal Toxicol 2013
What It Found
- The authors observed no interference from Dextromethorphan at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.
Keep in Mind
- This is a single challenge level.
- It cannot rule out interference at a higher concentration or with a different device.
Test Studied
- NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels
Levofloxacin
Source Colby et al., Clin Biochem 2019
What It Found
- Levofloxacin did not react with this dedicated methadone reagent in the modern fluoroquinolone comparison.
Keep in Mind
- Other assays in the same study were affected, including CEDIA buprenorphine and MULTIGENT opiates.
Test Studied
- Abbott MULTIGENT methadone
Meprobamate
Source Lin et al., J Anal Toxicol 2013
What It Found
- The authors observed no interference from Meprobamate at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.
Keep in Mind
- This is a single challenge level.
- It cannot rule out interference at a higher concentration or with a different device.
Test Studied
- NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels